Calpains participate in the development of inflammatory reaction;Les calpaïnes participent au développement de la réaction inflammatoire

Medecine/Sciences

Volumn 19, Issue 1, 2003, Pages 71-76

  Baud, Laurent ^a   Fouqueray, Bruno ^a   Bellocq, Agnès ^a   Peltier, Julie ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; CYSTEINE PROTEINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; CALCIUM MOBILIZATION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CYTOSOL; DRUG EFFECT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HORMONE RESISTANCE; INFLAMMATION; ISCHEMIA; MEDIATOR RELEASE; PATHOPHYSIOLOGY; REVIEW; TISSUE REPAIR; TUMOR GROWTH;

MAMMALIA;

EID: 0037234129     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200319171     Document Type: Review

References (27)

1. Sorimachi H, Suzuki K. The structure of calpain. J Biochem 2001; 129: 653-64.
2. Glading A, Lauffenburger DA, Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 2002; 12: 46-54.
3. Sato K, Kawashima S. Calpain function in the modulation of signal transduction molecules. Biol Chem 2001; 382: 743-51.
4. Arthur JSC, Elce JS, Hegadorn C, Williams K, Greer PA. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 2000; 20: 4474-81.
5. Azam M, Andrabi SS, Sahr KE, Kamath L, Kuliopulos A, Chishti AH. Disruption of the mouse m-calpain gene reveals an essential role in platelet function. Mol Cell Biol 2001; 21: 2213-20.
6. Permutt MA, Bernal-Mizrachi E, Inoue H. Calpain 10: the first positional cloning of a gene for type 2 diabetes? J Clin Invest 2000; 106: 819-21.
7. Baghdiguian S, Martin M, Richard I, et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkBa/NF-kB pathway in limb-girdle muscular dystrophy type 2A. Nature Med 1999; 5: 503-11.
8. Richard I, Roudaut C, Marchand S, et al. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IκBa/nuclear factor κB pathway perturbation in mice. J Cell Biol 2000; 151: 1583-90.
9. Shumway SD, Maki M, Miyamoto S. The PEST domain of IκBa is necessary and sufficient for in vitro degradation by m-calpain. J Biol Chem 1999; 274: 30874-81.
10. Chen F, Demers LM, Vallyathan V, Lu Y, Castranova V, Shi X. Impairment of NF-κB activation and modulation of gene expression by calpastatin. Am J Physiol 2000; 279: C709-16.
11. McDonald MC, Mota-Filipe H, Paul A, et al. Calpain inhibitor I reduces the activation of nuclear factor-κB and organ injury/dysfunction in hemorragic shock. FASEB J 2001; 15: 171-86.
12. Cuzzocrea S, McDonald MC, Mazzon E, et al. Calpain inhibitor I reduces the development of acute and chronic inflammation. Am J Pathol 2000; 157: 2065-79.
13. Cuzzocrea S, McDonald MC, Mazzon E, et al. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut 2001; 48: 478-88.
14. Cox EA, Huttenlocher A. Regulation of integrin-mediated adhesion during cell migration. Microsc Res Tech 1998; 43: 412-9.
15. Pontremoli S, Melloni E, Damiani G, et al. Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C. J Biol Chem 1988; 263: 1915-9.
16. Kavita U, Mizel SB. Differential sensitivity of interleukin-1 alpha and - beta precursor proteins to cleavage by calpain, a calcium-dependent protease. J Biol Chem 1995; 270: 27758-65.
17. Bellocq A, Doublier S, Suberville S, et al. Somatostatin increases glucocorticoid binding and signaling in macrophages by blocking the calpain-specific cleavage of Hsp 90. J Biol Chem 1999; 274: 56891-6.
18. Knepper-Nicolai B, Savill J, Brown SB. Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J Biol Chem 1998; 273: 30530-6.
19. Wang KK. Calpain and caspase: can you tell the difference? Trends Neurosci 2000; 23: 20-6.
20. Liu X, Rainey JJ, Harriman JF, Schnellmann RG. Calpains mediate acute renal cell death: role of autolysis and translocation. Am J Physiol 2001; 281: F728-38.
21. Szomor Z, Shimizu K, Yamamoto S, Yasuda T, Ishikawa H, Nakamura T. Externalization of calpain (calcium-dependent neutral cysteine proteinase) in human arthritic cartilage. Clin Exp Rheumatol 1999; 17: 569-74.
22. Deshpande RV, Goust JM, Chakrabarti AK, Barbosa E, Hogan EL, Banik NL. Calpain expression in lymphoid cells. Increased mRNA and protein levels after cell activation. J Biol Chem 1995; 270: 2497-505.
23. Kunimatsu M, Ma XJ, Nishimura J, et al. Neutrophil chemotactic activity of N-terminal peptides from the calpain small subunit. Biochem Biophys Res Commun 1990; 169: 1242-7.
24. Abe M, Oda N, Sato Y. Cell-associated activation of latent transforming growth factor-β by calpain. J Cell Physiol 1998; 174: 186-93.
25. Loew D, Perrault C, Morales M, et al. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry 2000; 39: 10812-22.
26. Mimory T, Suganuma K, Tanami Y, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumotic diseases. Proc Natl Acad Sci USA 1995; 92: 7267-71.
27. Vanderklish PW, Bahr BA. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 2000; 81: 323-39.